Name | Number of supported studies | Average coverage | |
---|---|---|---|
Mueller cell | 4 studies | 24% ± 7% | |
alveolar macrophage | 4 studies | 44% ± 14% |
Insufficient scRNA-seq data for expression of STAC at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 85% | 299.84 | 220 / 258 | 88% | 18.90 | 203 / 230 |
prostate | 97% | 1115.78 | 238 / 245 | 72% | 4.29 | 363 / 502 |
lung | 100% | 782.92 | 577 / 578 | 65% | 3.88 | 754 / 1155 |
kidney | 100% | 347.09 | 89 / 89 | 56% | 2.76 | 503 / 901 |
breast | 93% | 288.61 | 426 / 459 | 45% | 2.56 | 507 / 1118 |
uterus | 91% | 329.11 | 155 / 170 | 41% | 4.40 | 186 / 459 |
ovary | 63% | 104.80 | 113 / 180 | 60% | 2.40 | 257 / 430 |
bladder | 90% | 570.05 | 19 / 21 | 30% | 1.26 | 151 / 504 |
esophagus | 70% | 203.78 | 1009 / 1445 | 46% | 2.17 | 84 / 183 |
thymus | 43% | 64.00 | 278 / 653 | 63% | 4.28 | 383 / 605 |
blood vessel | 97% | 926.07 | 1300 / 1335 | 0% | 0 | 0 / 0 |
skin | 78% | 198.21 | 1411 / 1809 | 15% | 0.65 | 70 / 472 |
brain | 55% | 264.82 | 1447 / 2642 | 34% | 4.16 | 242 / 705 |
adipose | 85% | 315.40 | 1028 / 1204 | 0% | 0 | 0 / 0 |
intestine | 66% | 289.62 | 639 / 966 | 18% | 0.57 | 97 / 527 |
muscle | 68% | 126.32 | 546 / 803 | 0% | 0 | 0 / 0 |
pancreas | 1% | 1.11 | 4 / 328 | 63% | 2.53 | 112 / 178 |
stomach | 38% | 115.37 | 138 / 359 | 22% | 0.67 | 62 / 286 |
liver | 38% | 52.50 | 86 / 226 | 13% | 0.63 | 51 / 406 |
tonsil | 0% | 0 | 0 / 0 | 33% | 2.62 | 15 / 45 |
lymph node | 0% | 0 | 0 / 0 | 24% | 0.36 | 7 / 29 |
spleen | 19% | 22.63 | 45 / 241 | 0% | 0 | 0 / 0 |
heart | 15% | 19.60 | 130 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 4% | 0.12 | 3 / 80 |
peripheral blood | 2% | 3.68 | 23 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_2001259 | Biological process | positive regulation of cation channel activity |
GO_1903078 | Biological process | positive regulation of protein localization to plasma membrane |
GO_1901387 | Biological process | positive regulation of voltage-gated calcium channel activity |
GO_0003009 | Biological process | skeletal muscle contraction |
GO_0034605 | Biological process | cellular response to heat |
GO_0009898 | Cellular component | cytoplasmic side of plasma membrane |
GO_0030315 | Cellular component | T-tubule |
GO_0005829 | Cellular component | cytosol |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0044325 | Molecular function | transmembrane transporter binding |
Gene name | STAC |
Protein name | SH3 and cysteine rich domain SH3 and cysteine-rich domain-containing protein (Src homology 3 and cysteine-rich domain-containing protein) |
Synonyms | STAC1 |
Description | FUNCTION: Promotes expression of the ion channel CACNA1H at the cell membrane, and thereby contributes to the regulation of channel activity. Plays a minor and redundant role in promoting the expression of calcium channel CACNA1S at the cell membrane, and thereby contributes to increased channel activity. Slows down the inactivation rate of the calcium channel CACNA1C. . |
Accessions | E9PEA7 ENST00000427486.5 ENST00000273183.8 ENST00000434649.1 F8WB25 Q99469 Q8WUK8 C9J3Z9 ENST00000457375.6 |